S100A9 and psoriasis: In support of the Role of IL-17A in the Psoriasis Pathway, CXCL1, CXCL3, CXCL6, S100A8, S100A9, and CCL20 in the shared signature were all upregulated in both psoriatic skin and colon lesional tissues.